Matthias von Herrath

Matthias von Herrath

Company: Novo Nordisk

Job title: Vice President & Senior Medical Officer, Global Chief Medical Officer

Seminars:

BREAKOUT DISCUSSION GROUPS 12:00 pm

• What microstructures provide an immune protective environment to prevent sensitization and rejection? • What is the optimal pore size in membranes required for encapsulation and how does this effect the distance molecule have to travel, selectivity and permeability? • How long will cells survive in an encapsulation device and will the cells have to…Read more

day: Day One

CASE STUDY: Functional Enrichment for Insulin Producing Cells from hPSCs Large Scale Cultures Using Novel Cell Surface Markers Combination 11:00 am

• Using cell-capture antibody array, novel antibodies to distinguish hPSC-derived islets cell populations • Enriching for cells using a novel antibody combination and re-aggregation with MACS technology and large-scale cultures • In vitro and in vivo functional analysis for sorted cells • Strategy development for reducing required cell mass loaded into an encapsulation device to…Read more

day: Day One

CASE STUDY: Defining New Combination Therapies to Intervene in Type 1 Diabetes 9:40 am

• The issues of immunity and reoccurrence of autoimmunity and allorecognition • Strategies using stem cells to overcome allorecognition • Discussing capsules and implantationRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.